|
1
|
Oost W, Talma N, Meilof JF and Laman JD:
Targeting senescence to delay progression of multiple sclerosis. J
Mol Med (Berl). 96:1153–1166. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Childs BG, Durik M, Baker DJ and van
Deursen JM: Cellular senescence in aging and age-related disease:
From mechanisms to therapy. Nat Med. 21:1424–1435. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Alzheimer's Association. 2015 Alzheimer's
disease facts and figure. Alzheimers Dement. 11:332–384.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chiappini E, Bianconi M, Dalzini A,
Petrara MR, Galli L, Giaquinto C and De Rossi A: Accelerated aging
in perinatally HIV-infected children: Clinical manifestations and
pathogenetic mechanisms. Aging (Albany NY). 10:3610–3625.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cheng J, Yang H and Zhang J: Donepezil's
effects on brain functions of patients with Alzheimer disease: A
regional homogeneity study based on resting-state functional
magnetic resonance imaging. Clin Neuropharmacol. 42:42–48.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao QF, Tan L, Wang HF, Jiang T, Tan MS,
Tan L, Xu W, Li JQ, Wang J, Lai TJ and Yu JT: The prevalence of
neuropsychiatric symptoms in Alzheimer's disease: Systematic review
and meta-analysis. J Affect Disord. 190:264–271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kales HC, Zivin K, Kim HM, Valenstein M,
Chiang C, Ignacio RV, Ganoczy D, Cunningham F, Schneider LS and
Blow FC: Trends in antipsychotic use in dementia 1999-2007. Arch
Gen Psychiatry. 68:190–197. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Desmarais P, Massoud F, Filion J, Nguyen
QD and Bajsarowicz P: Quetiapine for psychosis in Parkinson disease
and neurodegenerative parkinsonian disorders: A systematic review.
J Geriatr Psychiatry Neurol. 29:227–236. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ooi CH, Yoon PS, How CH and Poon NY:
Managing challenging behaviours in dementia. Singapore Med J.
59:514–518. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Olivieri-Mui BL, Devlin JW, Ochoa A,
Schenck D and Briesacher B: Perceptions vs. evidence: Therapeutic
substitutes for antipsychotics in patients with dementia in
long-term care. Aging Ment Health. 22:544–549. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Herrmann N, Lanctôt KL, Rothenburg LS and
Eryavec G: A placebo-controlled trial of valproate for agitation
and aggression in Alzheimer's disease. Dement Geriatr Cogn Disord.
23:116–119. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Echeverria V, Barreto GE, Avila-Rodriguezc
M, Tarasov VV and Aliev G: Is VEGF a key target of cotinine and
other potential therapies against Alzheimer disease? Curr Alzheimer
Res. 14:1155–1163. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dubois B, Feldman HH, Jacova C, Dekosky
ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D,
Gauthier S, Jicha G, et al: Research criteria for the diagnosis of
Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet
Neurol. 6:734–746. 2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Armour C, Műllerová J and Elhai JD: A
systematic literature review of PTSD's latent structure in the
diagnostic and statistical manual of mental disorders: DSM-IV to
DSM-5. Clin Psychol Rev. 44:60–74. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mathys M: Pharmacologic management of
behavioral and psychological symptoms of major neurocognitive
disorder. Ment Health Clin. 8:284–293. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Quiroz JA, Tamburri P, Deptula D, Banken
L, Beyer U, Rabbia M, Parkar N, Fontoura P and Santarelli L:
Efficacy and safety of basimglurant as adjunctive therapy for major
depression: A randomized clinical trial. JAMA Psychiatry.
73:675–684. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Trivedi D: Cochrane review summary:
Mini-mental state examination (MMSE) for the detection of dementia
in clinically unevaluatedpeople aged 65 and over in community and
primary care populations. Prim Health Care Res Dev. 18:527–528.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Riedel BC, Thompson PM and Brinton RD:
Age, APOE and sex: Triad of risk of Alzheimer's disease. J Steroid
Biochem Mol Biol. 160:134–147. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
de Souza GA, da Silva SJ, Del Cistia CN,
Pitasse-Santos P, Pires LO, Passos YM, Cordeiro Y, Cardoso CM,
Castro RN, Sant'Anna CMR, et al: Discovery of novel dual-active
3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and
selective acetylcholinesterase inhibitor and antioxidant. J Enzyme
Inhib Med Chem. 34:631–637. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Desmidt T, Hommet C and Camus V:
Pharmacological treatments of behavioral and psychological symptoms
of dementia in Alzheimer's disease: Role of acetylcholinesterase
inhibitors and memantine. Geriatr Psychol Neuropsychiatr Vieil.
14:300–306. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nagata T, Shinagawa S, Nakajima S and
Mimura M: Association between neuropsychiatric improvement and
neurocognitive change in Alzheimer's disease: Analysis of the
CATIE-AD Study. J Alzheimers Dis. 66:139–148. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Geddes JR, Gardiner A, Rendell J, Voysey
M, Tunbridge E, Hinds C, Yu LM, Hainsworth J, Attenburrow MJ, Simon
J, et al: Comparative evaluation of quetiapine plus lamotrigine
combination versus quetiapine monotherapy (and folic acid versus
placebo) in bipolar depression (CEQUEL): A 2x2 factorial randomised
trial. Lancet Psychiatry. 3:31–39. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hoseinifar SH, Zoheiri F and Caipang CM:
Dietary sodium propionate improved performance, mucosal and humoral
immune responses in Caspian white fish (Rutilus frisii kutum) fry.
Fish Shellfish Immunol. 55:523–528. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Huang L, Jin Y, Gao Y, Thung KH and Shen
D: Alzheimer's disease neuroimaging initiative. Longitudinal
clinical score prediction in Alzheimer's disease with soft-split
sparse regression based random forest. Neurobiol Aging. 46:180–191.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Harris R, Miners JS, Allen S and Love S:
VEGFR1 and VEGFR2 in Alzheimer's disease. J Alzheimers Dis.
61:741–752. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Fong LK, Yang MM, Dos Santos Chaves R,
Reyna SM, Langness VF, Woodruff G, Roberts EA, Young JE and
Goldstein LSB: Full-length amyloid precursor protein regulates
lipoprotein metabolism and amyloid-β clearance in human astrocytes.
J Biol Chem. 293:11341–11357. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mateo I, Llorca J, Infante J,
Rodríguez-Rodríguez E, Fernández-Viadero C, Peña N, Berciano J and
Combarros O: Low serum VEGF levels are associated with Alzheimer's
disease. Acta Neurol Scand. 116:56–58. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kakinuma Y, Furihata M, Akiyama T, Arikawa
M, Handa T, Katare RG and Sato T: Donepezil, an
acetylcholinesterase inhibitor against Alzheimer's dementia,
promotes angiogenesis in an ischemic hindlimb model. J Mol Cell
Cardiol. 48:680–693. 2009.PubMed/NCBI View Article : Google Scholar
|
